Boston Private Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$17M Sell
264,187
-1,125
-0.4% -$70.4K 0.79% 41
2014
Q4
$15.7M Sell
265,312
-16,470
-6% -$929K 0.73% 43
2014
Q3
$14.4M Sell
281,782
-11,312
-4% -$565K 0.7% 46
2014
Q2
$14.2M Buy
293,094
+4,968
+2% +$245K 0.69% 45
2014
Q1
$15M Sell
288,126
-13,356
-4% -$711K 0.76% 39
2013
Q4
$16M Sell
301,482
-8,868
-3% -$452K 0.8% 38
2013
Q3
$14.4M Buy
310,350
+5,614
+2% +$246K 0.8% 36
2013
Q2
$13.6M Buy
+304,736
New +$13.2M 0.79% 34

Other funds holding BMY

Boston Private Bank & Trust's BMY Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its Bristol-Myers Squibb (BMY) stake by 0.42% in Q1 2015, selling an estimated $70.4K and leaving 264,187 shares worth $17M. The position accounts for 0.79% of the portfolio, ranked #41.

Boston Private Bank & Trust first reported a position in BMY in Q2 2013 and has held it in 8 quarters since. 1,450 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

  • Boston Private Bank & Trust held 264,187 shares of Bristol-Myers Squibb worth $17M as of Q1 2015.
  • Boston Private Bank & Trust sold 1,125 Bristol-Myers Squibb shares in Q1 2015, an estimated $70.4K.
  • Bristol-Myers Squibb made up 0.79% of Boston Private Bank & Trust's portfolio in Q1 2015, its #41 holding.
  • Boston Private Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 8 quarters since.
  • 1,450 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.